HSPG2 and prostate cancer: Perlecan and MMP-7 co-localize at tissue boundaries when surveyed in prostate cancer sections, with MMP-7 proposed to act as a molecular switch by altering cancer cell behavior to favor cell dispersion and invasiveness (222, 223).